Multiple sclerosis (relapsing-remitting) - fingolimod: Evidence Review Group discussion of manufacturer's reponse to second ACD
|
Multiple sclerosis (relapsing-remitting) - fingolimod: Evidence Review Group discussion of manufacturer's reponse to second ACD
16 March 2012 (27.6 Kb 8 sec) |
This page was last updated: 15 March 2012